XBiotech annual operating margin
2020
2021
2022
XBiotech Operating Margin Growth & History (XBIT)
XBiotech's operating margin was −860.10% for fiscal 2022.
View full XBiotech company overviewXBiotech annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-12-31 | −860.10% | −723.74 pp |
| 2021 | 2021-12-31 | −136.36% | −94.82 pp |
| 2020 | 2020-12-31 | −41.54% | — |
XBiotech quarterly operating margin
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q4 2022 | 2022-12-31 | −2,720.67% | −2560.82 pp |
| Q3 2022 | 2022-09-30 | −380.30% | −297.74 pp |
| Q2 2022 | 2022-06-30 | −790.46% | −556.09 pp |
| Q1 2022 | 2022-03-31 | −1,569.00% | −1495.74 pp |
| Q4 2021 | 2021-12-31 | −159.84% | −66.45 pp |
| Q3 2021 | 2021-09-30 | −82.56% | −38.29 pp |
| Q2 2021 | 2021-06-30 | −234.36% | −192.33 pp |
| Q1 2021 | 2021-03-31 | −73.26% | −56.14 pp |
| Q4 2020 | 2020-12-31 | −93.40% | — |
| Q3 2020 | 2020-09-30 | −44.27% | — |
| Q2 2020 | 2020-06-30 | −42.03% | — |
| Q1 2020 | 2020-03-31 | −17.12% | — |
XBiotech operating margin trends
Across the available reported history, XBiotech's operating margin decreased from −136.36% to −860.10%, a change of −723.74 percentage points. The latest reported quarter, Q4 2022, shows −2,720.67%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review XBiotech filings at SEC.gov ↗